info-at-broadviewventures-dot-org  :  617-457-5944

Broadview Ventures

June 2, 2009: miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients’ lives by developing innovative microRNA (miRNA) based therapeutics for cardiovascular and muscle disease…

May 13, 2009: CardiAQ Valve Technologies (CVT) received $750,000 in seed or ‘translational’ funding from Broadview Ventures Inc.